[1] Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2021,71(3):209-249. [2] 吴春晓,顾凯,龚杨明,等. 2015年中国结直肠癌发病和死亡情况分析[J]. 中国癌症杂志,2020,30(4):241-245. [3] Chen W,Zheng R,Zhang S,et al.Cancer incidence and mortality in China,2013[J]. Cancer Lett,2017,401:63-71. [4] Feng RM,Zong YN,Cao SM,et al.Current cancer situation in China:Good or bad news from the 2018 Global Cancer Statistics?[J]. Cancer Commun (Lond),2019,39(1):22. [5] Knudsen AB,Rutter CM,Peterse EFP,et al.Colorectal cancer screening:An updated modeling study for the US preventive services task force[J]. JAMA,2021,325(19):1998-2011. [6] Lin JS,Perdue LA,Henrikson NB,et al.Screening for colorectal cancer:Updated evidence report and systematic review for the US preventive services task force[J]. JAMA,2021,325(19):1978-1998. [7] Chen H,Li N,Ren J,et al.Participation and yield of a population-based colorectal cancer screening programme in China[J]. Gut,2019,68(8):1450-1457. [8] 董志伟. 中国癌症筛查及早诊早治指南[M]. 北京:北京大学医学出版社,2005:34-46. [9] 卫生部疾病预防控制局,癌症早诊早治项目专家委员会. 癌症早诊早治项目技术方案[M]. 北京:人民卫生出版社,2011:150-189. [10] World Health Organization.Guidelines for controlling and monitoring the tobacco epidemic[M]. Geneva:World Health Organization,1998:76-77. [11] World Health Organization.Global status report on alcohol and health 2014[M]. Geneva:World Health Organization,2014:4. [12] 李娟,李其龙,薛峰,等. 粪便潜血试验和问卷调查在人群结直肠癌筛查中的应用评价[J]. 中国肿瘤,2015,24(5):385-389. [13] 董佩,石菊芳,邱五七,等. 2015—2017年中国城市居民肿瘤防治健康素养现况及相关因素分析[J]. 中华预防医学杂志,2020,54(1):76-83. [14] Wang Y,Yang C,Li W,et al.Identification of colon tumor marker NKD1 via integrated bioinformatics analysis and experimental validation[J]. Cancer Med,2021,10(20):7383-7394. [15] 蔡振鑫. 胃功能三项、肿瘤标志物联合检测在胃癌早期筛查中的临床价值[J]. 中国医药科学,2021,11(23):159-161,194. [16] Giovanella L,Garo ML,Ceriani L,et al.Procalcitonin as an alternative tumor marker of medullary thyroid carcinoma[J]. J Clin Endocrinol Metab,2021,106(12):3634-3643. [17] Klabunde C,Blom J,Bulliard JL,et al.Participation rates for organized colorectal cancer screening programmes:An international comparison[J]. J Med Screen,2015,22(3):119-126. [18] Bretthauer M,Kaminski MF,Løberg M,et al.Population-Based colonoscopy screening for colorectal cancer:A randomized clinical trial[J]. JAMA Intern Med,2016,176(7):894-902. [19] Quintero E,Castells A,Bujanda L,et al.Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening[J]. N Engl J Med,2012,366(8):697-706. [20] Moss S,Mathews C,Day TJ,et al.Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test:Results from a pilot study within the national screening programme in England[J]. Gut,2017,66(9):1631-1644. [21] 郑荣寿,陈茹,韩冰峰,等. 2022年中国恶性肿瘤流行情况分析[J]. 中华肿癌杂志,2024,46(3):221-231. [22] 陈晶,时俊峰,徐莉,等. 南京市居民肿瘤早诊断意识现状及影响因素调查[J]. 华南预防医学,2022,48(11):1421-1424. [23] 李超,张质钢,徐珊珊,等. 郑州市居民恶性肿瘤防治健康素养调查[J]. 华南预防医学,2022,48(1):32-36. [24] 黄丽,彭山玲. 癌症患者健康素养现状及其影响因素[J]. 解放军护理杂志,2016,33(2):17-20,25. [25] 何丽娜,楼伊云,何金灿,等. 慢性肾脏病患者肿瘤发病情况和相关危险因素[J]. 中华肾脏病杂志,2020,36(6):487-491. [26] 李襄军,范小云,姚洁,等. 2型糖尿病住院患者合并恶性肿瘤的分布情况及相关危险因素分析[J]. 肿瘤预防与治疗,2015,28(3):127-130. [27] 余杰,道寿丽,刘艳,等. 老年妇科肿瘤合并急性肺栓塞患者的临床表现、长期预后和危险因素分析[J]. 中国心血管杂志,2020,25(6):555-558. |